封面
市场调查报告书
商品编码
1793395

2025年全球动物治疗与诊断市场报告

Animal Therapeutics And Diagnostics Global Market Report 2025

出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年动物治疗和诊断市场将强劲成长,到2029年将达到670.5亿美元,年复合成长率(CAGR)为6.8%。预测期内的成长可归因于宠物医疗保健支出的增加、兽药个人化医疗的推进、生物製药的扩张以及监管部门对创新的支持。预测期内的主要趋势包括生物技术的进步、数位健康融合、对预防保健的日益关注、动物精准医疗以及对伴侣动物治疗的需求不断增长。

我们对该市场未来五年6.8%的成长率预测与先前保持不变。下降主要源自于美国与其他国家之间关税的影响。对来自德国的一次性生物反应器袋和单株抗体树脂征收关税,可能会增加下一代生技药品的生产成本。此外,互惠关税以及不断升级的贸易紧张局势和限制对全球经济和贸易的负面影响可能会产生更广泛的影响。

宠物拥有量的快速成长预计将在短期内推动兽医治疗和诊断市场的成长。随着越来越多的人将宠物作为家庭成员饲养,人们对宠物健康的认识和兴趣日益增长,从而推动了对兽医治疗和诊断的需求。宠物饲主表现出愿意投资宠物的医疗保健,包括定期体检和预防措施。例如,2021年,美国一家专注于宠物用品的线上零售商Chewy Inc.报告称,其宠物收养约为977,202只,创下六年来的最高收养。因此,宠物拥有量的上升正在显着推动兽医治疗和诊断市场的发展。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场:宏观经济情景,包括利率、通膨、地缘政治、贸易战和关税,以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球动物治疗与诊断:PESTEL 分析(政治、社会、技术、环境、法律因素、驱动因素与限制因素)
  • 最终用途产业分析
  • 全球动物治疗与诊断市场:成长率分析
  • 全球动物治疗与诊断市场表现:规模与成长,2019-2024
  • 全球动物治疗与诊断市场预测:规模与成长,2024-2029 年,2034 年
  • 全球动物治疗与诊断:总目标市场(TAM)

第六章市场区隔

  • 全球动物治疗与诊断市场(按动物类型、表现和预测),2019-2024 年、2024-2029 年、2034 年
  • 伴侣动物
  • 家禽
  • 全球动物治疗与诊断市场:依产品、绩效及预测,2019-2024 年、2024-2029 年、2034 年
  • 动物诊断产品
  • 装置
  • 耗材
  • 动物治疗产品
  • 抗寄生虫药物和抗生素
  • 抗发炎药物
  • 麻醉剂
  • 全球动物治疗与诊断市场、伴侣动物(按类型细分):实际结果与预测,2019-2024 年、2024-2029 年、2034 年
  • 小型哺乳动物
  • 全球动物治疗与诊断市场(牛,按类型细分):实际结果和预测,2019-2024 年、2024-2029 年、2034 年
  • 乳牛
  • 肉牛
  • 全球动物治疗与诊断市场(猪,按类型细分):实际结果与预测,2019-2024 年、2024-2029 年、2034 年
  • 市场上的猪
  • 种猪
  • 全球动物治疗与诊断市场(家禽,按类型细分):实际结果和预测,2019-2024 年、2024-2029 年、2034 年
  • 肉鸡
  • 火鸡
  • 全球动物治疗与诊断市场(绵羊,按类型细分):实际结果和预测(2019-2024 年、2024-2029 年、2034 年)
  • 市场兰姆酒
  • 种母羊

第七章 区域和国家分析

  • 全球动物治疗与诊断市场:区域表现与预测,2019-2024 年、2024-2029 年、2034 年
  • 全球动物治疗与诊断市场:各国表现及预测,2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章:中国市场

第十章 印度市场

第十一章 日本市场

第十二章:澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章:德国市场

第十八章:法国市场

第十九章:义大利市场

第20章:西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章:加拿大市场

第26章 南美洲市场

第27章:巴西市场

第28章 中东市场

第29章:非洲市场

第30章:竞争格局与公司概况

  • 动物治疗与诊断市场:竞争格局
  • 动物治疗与诊断市场:公司简介
    • Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Boehringer Ingelheim Animal Health USA Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Virbac AH Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Ceva Animal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Heska Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章:其他领先和创新企业

  • IDEXX Laboratories Inc.
  • bioMerieux Inc.
  • Thermo Fisher Scientific Inc.
  • Randox Laboratories Ltd.
  • Bio-Rad Laboratories Inc.
  • Bayer Animal Health LLC
  • Eli Lilly and Company
  • Merck & Co. Inc. Animal Health Division
  • Sanofi-Aventis Animal Health Inc.
  • Elanco Animal Health Incorporated
  • BioNote Inc.
  • IDvet
  • BASF Corporation
  • Koninklijke DSM NV
  • Evonik Industries AG

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章:高潜力市场国家、细分市场与策略

  • 2029年动物治疗与诊断市场:提供新机会的国家
  • 2029年动物治疗与诊断市场:细分市场将带来新机会
  • 2029 年动物治疗与诊断市场:成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r23920u

Animal therapeutics involve the application of medical procedures to improve the health of animals, while animal diagnostics focus on identifying and analyzing illnesses that impact animals.

The primary animal types for animal therapeutics and diagnostics include companion animals, cattle, pigs, and poultry. Companion animals are defined as tame or domestic-bred animals that can readily fulfill their social needs as companions in homes or through close daily interaction with humans. The diverse range of products in this domain includes animal diagnostics products, instruments, consumables, and animal therapeutics products, such as anti-parasitic drugs, antibiotics, anti-inflammatory drugs, and anesthetics.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The rapid escalation of U.S. tariffs and the resulting trade tensions in spring 2025 are having a considerable impact on the veterinary healthcare sector, particularly in the supply of pharmaceuticals, medical devices, and animal care products. Increased duties on imported veterinary medicines, diagnostic equipment, surgical tools, and pet care supplies have driven up operational costs for veterinary clinics, animal hospitals, and livestock health providers, forcing them to either raise service charges or absorb reduced profit margins. The livestock and agricultural industries are facing similar pressures, as tariffs on feed additives, vaccines, and breeding equipment push up production costs and complicate animal health management. Furthermore, retaliatory tariffs in major export markets have weakened demand for U.S.-manufactured veterinary products, adding to revenue challenges. To navigate these headwinds, the sector must now focus on local sourcing, preventive healthcare strategies, and digital veterinary solutions to control costs while continuing to deliver quality animal care.

The animal therapeutics and diagnostics market research report is one of a series of new reports from The Business Research Company that provides animal therapeutics and diagnostics market statistics, including animal therapeutics and diagnostics industry global market size, regional shares, competitors with a animal therapeutics and diagnostics market share, detailed animal therapeutics and diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the animal therapeutics and diagnostics industry. This animal therapeutics and diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The animal therapeutics and diagnostics market size has grown strongly in recent years. It will grow from $48.99 billion in 2024 to $51.62 billion in 2025 at a compound annual growth rate (CAGR) of 5.4%. The growth in the historic period can be attributed to increased pet ownership, advancements in veterinary medicine, prevalence of animal diseases, government initiatives, globalization of veterinary services.

The animal therapeutics and diagnostics market size is expected to see strong growth in the next few years. It will grow to $67.05 billion in 2029 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to rising expenditure on pet healthcare, personalized medicine in veterinary care, expansion of biopharmaceuticals, regulatory support for innovation. Major trends in the forecast period include biotechnology advancements, digital health integration, increased focus on preventive healthcare, precision medicine for animals, rising demand for companion animal therapeutics.

The forecast of 6.8% growth over the next five years remains unchanged from the previous projection for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariffs on single-use bioreactor bags and monoclonal-antibody resins sourced from Germany threaten to inflate production costs for next-generation biologics. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The surge in pet adoption rates is anticipated to drive the progression of the animal therapeutics and diagnostics market in the foreseeable future. As more individuals embrace pets as part of their families, heightened awareness and concern for their well-being have increased the demand for animal treatments and diagnostics. Pet owners demonstrate a willingness to invest in their pets' medical care, encompassing routine check-ups and preventive measures. For instance, in 2021, Chewy Inc., an online retailer in the US specializing in pet products, reported a record-breaking adoption rate of around 977,202 pets, marking the highest adoption rate in six years. Consequently, the escalating rate of pet adoptions significantly propels the animal therapeutics and diagnostics market.

The escalating prevalence of dermatological ailments is forecasted to fuel the expansion of the animal therapeutics and diagnostics market moving forward. Dermatological diseases encompass a wide spectrum of medical conditions impacting the skin, influenced by environmental factors, genetic predispositions, allergies, infections, and lifestyle alterations among animals. With pet owners increasingly prioritizing their animals' well-being and seeking veterinary interventions for dermatological concerns, there's a surge in demand for effective treatments. Moreover, heightened awareness regarding zoonotic diseases, transferable between animals and humans, accentuates the necessity for managing and treating skin conditions in animals. For example, as of October 2022, according to the British Broadcasting Corporation, India witnessed over 2.4 million animals affected by Lumpy Skin Disease, leading to the demise of more than 110,000 cattle. Consequently, the escalating burden of dermatological diseases significantly propels the growth of the animal therapeutics and diagnostics market.

Innovation stands as a pivotal trend gaining traction within the animal therapeutics and diagnostics market. Noteworthy enterprises within this sector are actively developing pioneering technologies to fortify their market presence. As an illustration, in December 2022, EKF Diagnostics, a UK-based company specializing in in vitro diagnostics, unveiled an updated version of the Lactate Scout analyzer tailored for veterinary applications. The enhanced analyzer offers species selection specifically designed for companion animals and cattle, rendering it suitable for implementation in both small and large animal healthcare practices.

Prominent entities operating within the animal therapeutics and diagnostics domain are spearheading innovations, notably telemedicine platforms catering to pet healthcare, in a bid to secure a competitive advantage. Telemedicine encompasses remote diagnosis, consultation, treatment, and monitoring of patients through telecommunication technologies such as video conferencing, phone calls, or secure messaging platforms. For instance, in June 2023, Cargill Inc., a US-based food corporation, introduced Zoonivet, a digital pet-care app. This Telehealth platform streamlines pet healthcare by facilitating video consultations between pet owners and qualified veterinarians, offering accessible and convenient primary pet care services. Zoonivet also plans to extend its services to include surgeries, home diagnostic services, medication, pet food, and pet boarding in key Indian markets.

In October 2023, Zomedica, a U.S.-based veterinary health company, announced its acquisition of Qorvo Biotechnologies LLC (QBT) for an undisclosed amount. This acquisition enables Zomedica to integrate Qorvo's innovative diagnostic technologies into its existing product portfolio, which includes advanced biosensing and diagnostic platforms that enhance the accuracy and speed of veterinary testing. Qorvo Biotechnologies LLC is based in the U.S. and focuses on developing point-of-care (POC) diagnostic solutions.

Major companies operating in the animal therapeutics and diagnostics market include Zoetis Inc., Boehringer Ingelheim Animal Health USA Inc., Virbac AH Inc., Ceva Animal Health Inc., Heska Corporation, IDEXX Laboratories Inc., bioMerieux Inc., Thermo Fisher Scientific Inc., Randox Laboratories Ltd., Bio-Rad Laboratories Inc., Bayer Animal Health LLC, Eli Lilly and Company, Merck & Co. Inc. Animal Health Division, Sanofi-Aventis Animal Health Inc., Elanco Animal Health Incorporated, BioNote Inc., IDvet, BASF Corporation, Koninklijke DSM N.V., Evonik Industries AG, MSD Animal Health, Vetoquinol S.A., Phibro Animal Health Corporation, Dechra Pharmaceuticals PLC, Kindred Biosciences Inc., Neogen Corporation, Abaxis Inc., QIAGEN N.V., Pfizer Animal Health, Norbrook Laboratories Limited

North America was the largest region in the animal therapeutics and diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global animal therapeutics and diagnostics market report during the forecast period. The regions covered in the animal therapeutics and diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the animal therapeutics and diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The animal therapeutics and diagnostics market include revenues earned by entities by providing services related to identifying and determining whether an animal has any viral, bacterial, parasitic, or other types of illnesses and related technologies such as clinical biochemistry, immunodiagnostics, molecular diagnostics, hematology, urinalysis, microbiology, and histopathology tests. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Animal Therapeutics And Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on animal therapeutics and diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for animal therapeutics and diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The animal therapeutics and diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Animal Type: Companion Animals; Cattle; Pigs; Poultry; Sheep
  • 2) By Product: Animal Diagnostics Products; Instruments; Consumables; Animal Therapeutics Products; Anti-Parasitic Drugs And Antibiotics; Anti-Inflammatory Drugs; Anesthetics
  • Subsegments:
  • 1) By Companion Animals: Dogs; Cats; Small Mammals
  • 2) By Cattle: Dairy Cattle; Beef Cattle
  • 3) By Pigs: Market Pigs; Breeding Pigs
  • 4) By Poultry: Broilers; Layers; Turkeys
  • 5) By Sheep: Market Lambs; Breeding Ewes
  • Companies Mentioned: Zoetis Inc.; Boehringer Ingelheim Animal Health USA Inc.; Virbac AH Inc.; Ceva Animal Health Inc.; Heska Corporation; IDEXX Laboratories Inc.; bioMerieux Inc.; Thermo Fisher Scientific Inc.; Randox Laboratories Ltd.; Bio-Rad Laboratories Inc.; Bayer Animal Health LLC; Eli Lilly and Company; Merck & Co. Inc. Animal Health Division; Sanofi-Aventis Animal Health Inc.; Elanco Animal Health Incorporated; BioNote Inc.; IDvet; BASF Corporation; Koninklijke DSM N.V.; Evonik Industries AG; MSD Animal Health; Vetoquinol S.A.; Phibro Animal Health Corporation; Dechra Pharmaceuticals PLC; Kindred Biosciences Inc.; Neogen Corporation; Abaxis Inc.; QIAGEN N.V.; Pfizer Animal Health; Norbrook Laboratories Limited
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Animal Therapeutics And Diagnostics Market Characteristics

3. Animal Therapeutics And Diagnostics Market Trends And Strategies

4. Animal Therapeutics And Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Animal Therapeutics And Diagnostics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Animal Therapeutics And Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Animal Therapeutics And Diagnostics Market Growth Rate Analysis
  • 5.4. Global Animal Therapeutics And Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Animal Therapeutics And Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Animal Therapeutics And Diagnostics Total Addressable Market (TAM)

6. Animal Therapeutics And Diagnostics Market Segmentation

  • 6.1. Global Animal Therapeutics And Diagnostics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Companion Animals
  • Cattle
  • Pigs
  • Poultry
  • Sheep
  • 6.2. Global Animal Therapeutics And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Animal Diagnostics Products
  • Instruments
  • Consumables
  • Animal Therapeutics Products
  • Anti-Parasitic Drugs And Antibiotics
  • Anti-Inflammatory Drugs
  • Anesthetics
  • 6.3. Global Animal Therapeutics And Diagnostics Market, Sub-Segmentation Of Companion Animals, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Dogs
  • Cats
  • Small Mammals
  • 6.4. Global Animal Therapeutics And Diagnostics Market, Sub-Segmentation Of Cattle, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Dairy Cattle
  • Beef Cattle
  • 6.5. Global Animal Therapeutics And Diagnostics Market, Sub-Segmentation Of Pigs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Market Pigs
  • Breeding Pigs
  • 6.6. Global Animal Therapeutics And Diagnostics Market, Sub-Segmentation Of Poultry, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Broilers
  • Layers
  • Turkeys
  • 6.7. Global Animal Therapeutics And Diagnostics Market, Sub-Segmentation Of Sheep, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Market Lambs
  • Breeding Ewes

7. Animal Therapeutics And Diagnostics Market Regional And Country Analysis

  • 7.1. Global Animal Therapeutics And Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Animal Therapeutics And Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Animal Therapeutics And Diagnostics Market

  • 8.1. Asia-Pacific Animal Therapeutics And Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Animal Therapeutics And Diagnostics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Animal Therapeutics And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Animal Therapeutics And Diagnostics Market

  • 9.1. China Animal Therapeutics And Diagnostics Market Overview
  • 9.2. China Animal Therapeutics And Diagnostics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Animal Therapeutics And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Animal Therapeutics And Diagnostics Market

  • 10.1. India Animal Therapeutics And Diagnostics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Animal Therapeutics And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Animal Therapeutics And Diagnostics Market

  • 11.1. Japan Animal Therapeutics And Diagnostics Market Overview
  • 11.2. Japan Animal Therapeutics And Diagnostics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Animal Therapeutics And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Animal Therapeutics And Diagnostics Market

  • 12.1. Australia Animal Therapeutics And Diagnostics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Animal Therapeutics And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Animal Therapeutics And Diagnostics Market

  • 13.1. Indonesia Animal Therapeutics And Diagnostics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Animal Therapeutics And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Animal Therapeutics And Diagnostics Market

  • 14.1. South Korea Animal Therapeutics And Diagnostics Market Overview
  • 14.2. South Korea Animal Therapeutics And Diagnostics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Animal Therapeutics And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Animal Therapeutics And Diagnostics Market

  • 15.1. Western Europe Animal Therapeutics And Diagnostics Market Overview
  • 15.2. Western Europe Animal Therapeutics And Diagnostics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Animal Therapeutics And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Animal Therapeutics And Diagnostics Market

  • 16.1. UK Animal Therapeutics And Diagnostics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Animal Therapeutics And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Animal Therapeutics And Diagnostics Market

  • 17.1. Germany Animal Therapeutics And Diagnostics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Animal Therapeutics And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Animal Therapeutics And Diagnostics Market

  • 18.1. France Animal Therapeutics And Diagnostics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Animal Therapeutics And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Animal Therapeutics And Diagnostics Market

  • 19.1. Italy Animal Therapeutics And Diagnostics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Animal Therapeutics And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Animal Therapeutics And Diagnostics Market

  • 20.1. Spain Animal Therapeutics And Diagnostics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Animal Therapeutics And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Animal Therapeutics And Diagnostics Market

  • 21.1. Eastern Europe Animal Therapeutics And Diagnostics Market Overview
  • 21.2. Eastern Europe Animal Therapeutics And Diagnostics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Animal Therapeutics And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Animal Therapeutics And Diagnostics Market

  • 22.1. Russia Animal Therapeutics And Diagnostics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Animal Therapeutics And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Animal Therapeutics And Diagnostics Market

  • 23.1. North America Animal Therapeutics And Diagnostics Market Overview
  • 23.2. North America Animal Therapeutics And Diagnostics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Animal Therapeutics And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Animal Therapeutics And Diagnostics Market

  • 24.1. USA Animal Therapeutics And Diagnostics Market Overview
  • 24.2. USA Animal Therapeutics And Diagnostics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Animal Therapeutics And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Animal Therapeutics And Diagnostics Market

  • 25.1. Canada Animal Therapeutics And Diagnostics Market Overview
  • 25.2. Canada Animal Therapeutics And Diagnostics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Animal Therapeutics And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Animal Therapeutics And Diagnostics Market

  • 26.1. South America Animal Therapeutics And Diagnostics Market Overview
  • 26.2. South America Animal Therapeutics And Diagnostics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Animal Therapeutics And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Animal Therapeutics And Diagnostics Market

  • 27.1. Brazil Animal Therapeutics And Diagnostics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Animal Therapeutics And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Animal Therapeutics And Diagnostics Market

  • 28.1. Middle East Animal Therapeutics And Diagnostics Market Overview
  • 28.2. Middle East Animal Therapeutics And Diagnostics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Animal Therapeutics And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Animal Therapeutics And Diagnostics Market

  • 29.1. Africa Animal Therapeutics And Diagnostics Market Overview
  • 29.2. Africa Animal Therapeutics And Diagnostics Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Animal Therapeutics And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Animal Therapeutics And Diagnostics Market Competitive Landscape And Company Profiles

  • 30.1. Animal Therapeutics And Diagnostics Market Competitive Landscape
  • 30.2. Animal Therapeutics And Diagnostics Market Company Profiles
    • 30.2.1. Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Boehringer Ingelheim Animal Health USA Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Virbac AH Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Ceva Animal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Heska Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Animal Therapeutics And Diagnostics Market Other Major And Innovative Companies

  • 31.1. IDEXX Laboratories Inc.
  • 31.2. bioMerieux Inc.
  • 31.3. Thermo Fisher Scientific Inc.
  • 31.4. Randox Laboratories Ltd.
  • 31.5. Bio-Rad Laboratories Inc.
  • 31.6. Bayer Animal Health LLC
  • 31.7. Eli Lilly and Company
  • 31.8. Merck & Co. Inc. Animal Health Division
  • 31.9. Sanofi-Aventis Animal Health Inc.
  • 31.10. Elanco Animal Health Incorporated
  • 31.11. BioNote Inc.
  • 31.12. IDvet
  • 31.13. BASF Corporation
  • 31.14. Koninklijke DSM N.V.
  • 31.15. Evonik Industries AG

32. Global Animal Therapeutics And Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Animal Therapeutics And Diagnostics Market

34. Recent Developments In The Animal Therapeutics And Diagnostics Market

35. Animal Therapeutics And Diagnostics Market High Potential Countries, Segments and Strategies

  • 35.1 Animal Therapeutics And Diagnostics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Animal Therapeutics And Diagnostics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Animal Therapeutics And Diagnostics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer